PPD to present at second annual World Pharma Trials

March 16, 2010 By: NCTechNews Category: Contract Research Organization

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced Simon Britton, vice president of clinical development, Asia Pacific, is a guest speaker at the World Pharma Trials 2010 conference in Singapore. His presentation will address the effectiveness of Asia’s people, infrastructure and CROs in supporting the region’s growing drug development activities. PPD is a silver sponsor of this year’s event.

Britton will join a panel of experts in analyzing supply versus demand of investigator sites, clinical trial experts, qualified partners and other drug development resources in Asia. The panel will also evaluate how well Asia is handling the increase of global biopharmaceutical companies moving their drug development programs into the region and innovative strategies to access untapped emerging countries. The presentation is Wednesday, March 17, at 11:55 a.m. UTC.

Britton provides strategic leadership for PPD’s clinical research business throughout Asia Pacific and plays an integral role in the company’s growth and development in the region.

PPD is one of the largest CROs in Asia Pacific with more than 1,400 employees and offices in 10 countries. In 2009, PPD acquired Excel PharmaStudies and BioDuro, strengthening its full range of drug discovery and development services and ability to provide scientific and technical expertise, global reach and a local understanding of clinical research in the region.

World Pharma Trials Asia brings together leaders from biopharmaceutical companies and CROs to explore a broad range of offshoring and outsourcing topics. The Asia drug development market is doubling in size each year as more global pharmaceutical companies conduct their clinical research programs in this growing region.

PPD is a leading global contract research organization, celebrating 25 years of providing discovery and development services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 40 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and commitment to quality to help clients and partners maximize returns on R&D investments that accelerate the delivery of safe, effective therapeutics. For more information, visit www.ppdi.com.

Comments are closed.

  • Controlling Quality

    An RTP firm is gaining international notoriety as a leader in analytical instrumentation for the pharmaceutical and chemical manufacturing industries, sharing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, presenting on emerging multi-variant approaches to obtaining immediate, unambiguous results from drug product samples at a recent major international tradeshow.

    Portable Power

    Alternative energy solutions provider INI Power Systems, Inc. recently marked its ten-year anniversary by unveiling the innovative new Trinity™ series of portable alternative energy hybrid solutions at two major events catering to the defense and emergency first responder marketplaces, with attendees searching for reliable, flexible power systems with multiple applications.

    EV Innovation

    Morrisville-based green transportation pioneer Evatran™ recently hosted a demonstration of its Plugless Power™ hands-free electric vehicle (EV) charging system, showcasing cost savings and convenience of EV usage in residential, commercial and public applications.

    guide to success

    Entrepreneurs now have a workbook to guide them through successful implementation of business building blocks thanks to a new goal-setting toolkit for personal and professional success available at no charge from a Cary-based international strategic business consultant.

    Packaging Cures

    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus

    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

  • Recent Headlines



free web site traffic and promotion